Actelion (VTX:ATLN) and Sanofi (NYSE:SNY) are reportedly in talks to reach a takeover deal after Johnson & Johnson (NYSE:JNJ) said yesterday that it has closed negotiations with the Swiss biotech. J&J and Actelion have been in informal talks for nearly 2 months and the US company has made an offer valued at 250 Swiss francs per share.
J&J said yesterday that it “was not able to reach an agreement that it believed would create adequate value for its shareholders.” Actelion told the company that it could attract offers that are significantly higher than the one made by J&J, according to Reuters.
Get the full story at our sister site, Drug Delivery Business News.
The post Actelion, Sanofi in talks after J&J backs out of negotiations appeared first on MassDevice.